Curaleaf Reports $320M in Q3 Revenue; Net Loss of $54.5M | Where to order Skittles Moonrock online
Learn where to order CBD Oil online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
đ Click here to Visit our shop! đ
[PRESS RELEASE] â STAMFORD, Conn., Nov. 5, 2025 â Curaleaf Holdings Inc., a leading international provider of consumer products in cannabis, reported its financial and operating results for the third quarter ended Sept. 30, 2025. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.
Boris Jordan, chairman and CEO of Curaleaf, stated, “We generated third quarter revenue of $320Â million, up 2% sequentially. Price compression continued to be a headwind, yet our domestic segment remained stable and achieved modest growth. Our international segment continued its strong trajectory, delivering 12% sequential growth and 56% year-over-year growth. Adjusted gross margin improved to 50%, an increase of 115 basis points both sequentially and versus the prior year. Adjusted EBITDA was $69Â million, representing a 22% margin, inclusive of a 200-basis-point drag from our international and hemp businesses.
Post Third Quarter 2025 Operational Highlights Balance Sheet and Cash Flow As of Sept. 30, 2025, the company had $107.5 million of cash and $543.7 million of outstanding debt, net of unamortized debt discounts and deferred financing fees. During the nine months ended Sept. 30, 2025, Curaleaf invested $47.9 million in capital expenditures, focused on facility upgrades, automation and selective retail expansion in strategic markets. Shares Outstanding The company’s weighted average shares outstanding were 764,825,622 and 742,535,355 for the third quarter of 2025 and 2024, respectively. The company’s weighted average shares outstanding were 758,809,812 and 739,833,334 for the nine months ended Sept. 30, 2025, and 2024, respectively.(1) Adjusted EBITDA, adjusted net income (loss), adjusted gross profit and free cash flow are non-GAAP financial measures, and adjusted EBITDA margin, adjusted net income (loss) per share and adjusted gross profit margin are non-GAAP financial ratios, in each case without a standardized definition under U.S. GAAP and which may not be comparable to similar measures used by other issuers. See “Non-GAAP Financial Performance Measures” in the companyâs press release for definitions and more information regarding Curaleaf’s use of non-GAAP financial measures and non-GAAP financial ratios. See “Reconciliation of Non-GAAP financial measures” for a reconciliation of each non-GAAP financial measure used in this press release from the most directly comparable U.S. GAAP financial measure.
Leave a Reply
Want to join the discussion?Feel free to contribute!